Areteia
PrivateLast Round
Series A
Extension
2/13/2024
Total Funding Raised
$425M
Company Overview
Areteia Therapeutics is a biopharmaceutical company developing an oral medication designed to assist patients with eosinophilic asthma by inhibiting eosinophil maturation to prevent airway damage, potentially providing a more accessible treatment option for millions and empowering them to better manage their condition.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Areteia Comps
Public and private peers based on sector, stage, and business model.
Areteia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | 2/13/2024 | ||||
| Series A | 7/12/2022 |
Key People
Founding team and executive leadership
Areteia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maverick Capital | Series A, Series A Extension |
| Access Industries | Series A, Series A Extension |
| Bain Capital Life Sciences | Series A, Series A Extension |
| GV | Series A, Series A Extension |
| Maverick Capital | Series A, Series A Extension |
| ARCH Venture Partners | Series A, Series A Extension |
| Viking Global Investors | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2025
Ian F. Smith appointed Chair of the Audit Committee.
- Mar 26, 2025
Donald J. Hayden, Jr. appointed as Chair of the Board.
Areteia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Areteia's valuation, stock price, and market status.
